Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Medical Economics|April 24, 2020
Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid-dependent asthma in SwedenMaria Andersson, Christer Janson, Thomas Kristensen, et al.
ERJ Open Research|January 28, 2025
Systemic corticosteroid dose-response effects in asthma: an observational cohort studyXiao Xu, Trung N Tran, Sarowar Golam, et al.
Current Medical Research and Opinion|July 27, 2018
Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatmentStephanie Chen, Sarowar Golam, Julie Myers, et al.
The European Respiratory Journal|October 13, 2018
Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic reviewArnaud Bourdin, Don Husereau, Nicolas Molinari, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 17, 2020
Matching-adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologicsArnaud Bourdin, Don Husereau, Nicolas Molinari, et al.
Thorax|September 18, 2017
Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general populationMarjan Kerkhof, Trung N Tran, Joan B Soriano, et al.
Journal of Comparative Effectiveness Research|May 13, 2022
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosusIan N Bruce, Sarowar Golam, Jason Steenkamp, et al.
Pageof 1